Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| NSC305787 hydrochloride | C25H31Cl3N2O | 53868-26-1 | Details |
| NTP42 | C25H23F2N3O5S | 2055599-51-2 | Details |
| Ilginatinib | C21H20FN7 | 1239358-86-1 | Details |
| Fludazonium chloride | C26H20Cl4FN2O2*Cl | 53597-28-7 | Details |
| Ilginatinib maleate | C25H24FN7O4 | 1354799-87-3 | Details |
| Ilginatinib hydrochloride | C21H21ClFN7 | 1239358-85-0 | Details |
| NSP-805 | C17H19N3O2 | 125068-54-4 | Details |
| OICR-0547 | C28H29F3N4O4 | 1801873-49-3 | Details |
| Olanzapine D3；LY170053 D3 | C17H20N4S | 786686-79-1 | Details |
| Erdosteine | C8H11NO4S2 | 84611-23-4 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| NVS-ZP7-4 | C28H28FN5OS | 2349367-89-9 | Details |
| Olaparib-d5；Olaparib D5;KU0059436 D5;AZD2281 D5 | C24H23FN4O3 | 2143107-56-4 | Details |
| Benzyl-α-GalNAc | C15H21NO6 | 3554-93-6 | Details |
| O-Propargyl-Puromycin | C24H29N7O5 | 1416561-90-4 | Details |
| Octadecanedioic acid | C18H34O4 | 871-70-5 | Details |
| NUCC-390 | C23H33N5O | 1060524-97-1 | Details |
| NV-5138 | C7H13F2NO2 | 2095886-80-7 | Details |
| Cefuroxime axetil | C20H22N4O10S | 64544-07-6 | Details |
| O-Desmethyl apixaban | C24H23N5O4 | 503612-76-8 | Details |
| NXT629 | C35H39N5O3S | 1454925-59-7 | Details |
| Cefonicid sodium；Monocid sodium;Cefonicid disodium salt | C18H19N6NaO8S3 | 61270-78-8 | Details |
| O-Desmethyl Midostaurin；O-Desmethyl PKC412;CGP62221 | C34 H28 N4 O4 | 740816-86-8 | Details |
| O-Methyl Atorvastatin hemicalcium | C67H68Ca2F2N4O10 | 887196-29-4 | Details |
| Obtusifoliol | C30H50O | 16910-32-0 | Details |
| ODM-204 | C20H21F3N4 | 1642818-64-1 | Details |
| Odapipam；NNC 756 | C19H20ClNO2 | 131796-63-9 | Details |
| NVP-CGM097 sulfate；CGM097 sulfate | C38H49ClN4O8S | 1313367-56-4 | Details |
| Olcegepant hydrochloride；BIBN-4096 hydrochloride;BIBN4096BS hydrochloride | C38H48Br2ClN9O5 | 586368-06-1 | Details |
| NSC624206 | C19H33Cl2NS2 | 13116-77-3 | Details |
| NVS-CRF38 | C19H21N5O2 | 1207258-55-6 | Details |
| NVP-QAV-572 | C17H19F2N7O3S2 | 957209-68-6 | Details |
| Oleanolic acid hemiphthalate disodium salt | C38H53NaO6 | 168770-31-8 | Details |
| Olcegepant | C38H47Br2N9O5 | 204697-65-4 | Details |
| Siremadlin (R Enantiomer)；HDM201 R Enantiomer;NVP-HDM201 R Enantiomer;Siremadlin R Enantiomer | C26H24Cl2N6O4 | 1448867-42-2 | Details |
| NSC305787 | C25H30Cl2N2O | 785718-37-8 | Details |
| Oleoylethanolamide | C20H39NO2 | 111-58-0 | Details |
| Oleuropeinic acid | C25H30O15 | 96382-90-0 | Details |
| Oleoylcarnitine | C25H47NO4 | 38677-66-6 | Details |
| Pamabrom | C11H18BrN5O3 | 606-04-2 | Details |
| Oligomycin B | C45H72O12 | 11050-94-5 | Details |
| Oligomycin C | C45H74O10 | 11052-72-5 | Details |
| OMDM-1；(Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide | C27H45NO3 | 616884-62-9 | Details |
| Olmesartan-d4；RNH-6270 D4;Olmesartan D4 | C24H22N6O3D4 | 1420880-41-6 | Details |
| OM-189 | C24H36N6O3S | 55381-18-5 | Details |
| Tirabrutinib hydrochloride | C25H23ClN6O3 | 1439901-97-9 | Details |
| OR-1896 | C13H15N3O2 | 220246-81-1 | Details |
| ON 146040 | C24H23N7O3S | 1404231-34-0 | Details |
| Org-10490 | C17H19NO | 83507-02-2 | Details |
| Omeprazole metabolite Omeprazole sulfone | C17H19N3O4S | 88546-55-8 | Details |
| Omeprazole-d3；H 16868 D3;Omeprazole D3 | C17H16D3N3O3S | 922731-01-9 | Details |
| Org30958 | C21H30O2S2 | 99957-90-1 | Details |
| Orelabrutinib | C26H25N3O3 | 1655504-04-3 | Details |
| Mepyramine maleate | C21H27N3O5 | 59-33-6 | Details |
| OP-1074 | C29H31NO4 | 1443752-76-8 | Details |
| Ophiobolin B | C25H38O4 | 5601-74-1 | Details |
| Opioid receptor modulator 1 | C18H23NO2 | 77514-44-4 | Details |
| Oral antiplatelet agent 1 | C23H24N4O5S | 2299200-91-0 | Details |
| Pilocarpine nitrate | C11H17N3O5 | 148-72-1 | Details |
| OMDM-2 | C27H45NO3 | 616884-63-0 | Details |
| OMDM-5 | C26H44N2O3 | 616884-66-3 | Details |
| OMDM-3 | C29H43NO3 | 616884-64-1 | Details |
| OMDM-4 | C29H43NO3 | 616884-65-2 | Details |
| OMDM-6 | C28H42N2O3 | 616884-67-4 | Details |
| p38-α MAPK-IN-1 | C27H35N5O3 | 443913-15-3 | Details |
| ARRY-797 | C22H26F2N4O2 | 1034189-82-6 | Details |
| Oxythiamine diphosphate | C12H17N3O8P2S | 10497-04-8 | Details |
| Oxythiamine；Hydroxythiamin | C12H17Cl2N3O2S | 136-16-3 | Details |
| Palbinone | C22H30O4 | 139954-00-0 | Details |
| p53 and MDM2 proteins-interaction-inhibitor (racemic)；p53-and-mdm2-proteins-interaction-inhibitor-racemic | C40H49Cl2N5O4 | 939983-14-9 | Details |
| p53 and MDM2 proteins-interaction-inhibitor (chiral)；p53-and-mdm2-proteins-interaction-inhibitor-chiral | C40H49Cl2N5O4 | 939981-37-0 | Details |
| Oxidopamine hydrobromide | C8H12BrNO3 | 636-00-0 | Details |
| Oxidopamine hydrochloride | C8H12ClNO3 | 28094-15-7 | Details |
| Lincomycin hydrochloride monohydrate | C18H37ClN2O7S | 7179-49-9 | Details |
| CBP/p300-IN-5；P300/CBP-IN-5 | C29H27F5N6O4 | 1889284-33-6 | Details |
| OSMI-4 | C27H26ClN3O7S2 | 2260791-14-6 | Details |
| OT-82 | C26H21FN4O | 1800487-55-1 | Details |
| OT-R antagonist 2；Oxytocin receptor antagonist 2 | C28H29N3O4 | 364071-16-9 | Details |
| OT-R antagonist 1；Oxytocin receptor antagonist 1 | C28H29N3O4 | 364071-17-0 | Details |
| OT antagonist 1 | C22H22N4O3 | 479080-38-1 | Details |
| OT antagonist 3 | C21H20N6O2 | 925703-75-9 | Details |
| Oxaquin；MCB-3837;DNV3837 | C31H33F2N4O11P | 790704-50-6 | Details |
| OXFBD04 | C17H16N2O3 | 2231747-03-6 | Details |
| 5,5-Dimethyloxazolidine-2,4-dione | C5H7NO3 | 695-53-4 | Details |
| Oxolinic acid | C13H11NO5 | 14698-29-4 | Details |
| Oxotremorine M iodide | C11H19IN2O | 3854-04-4 | Details |
| ORM-10962 | C27H29N3O4 | 763926-98-3 | Details |
| P-gp modulator 1 | C41H72N2O6 | 2249749-39-9 | Details |
| Benzquinamide；BZQ;Benzoquinamide;P2647 | C22H32N2O5 | 63-12-7 | Details |
| OTS186935 | C25H26ClN5O2 | 2093400-18-9 | Details |
| OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
| P-gp inhibitor 1 | C32H31N5O2 | 2050747-49-2 | Details |
| Orotic acid-6-C14 | C5H4N2O4 | 13186-54-4 | Details |
| OSMI-2 | C26H25N3O7S2 | 2260542-60-5 | Details |
| ORL1 antagonist 1 | C20H22ClN5 | 1174985-59-1 | Details |
| Ornidazole (Levo-) | C7H10ClN3O3 | 166734-83-4 | Details |
| ORM-10103 | C20H16N2O4 | 488847-28-5 | Details |
| ORM-15341 | C19H17ClN6O2 | 1297537-33-7 | Details |
| OSMI-3 | C32H35N3O9S2 | 2260791-13-5 | Details |
| CBP/p300-IN-3 | C24H29N7O | 2299226-01-8 | Details |
| Product Total： Product Page： | ||||
| 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 | ||||